Reverba Announces Appointment of Scott Wolf as Chief Growth Officer

Experienced expert in scaling business and growing revenue will expand Reverba’s global market reach. Seattle, WA – Reverba, a global health engagement company specializing in innovative and compliant patient engagement and medical communication solutions for biopharmaceutical companies, today announced the appointment of Scott Wolf as the company’s Chief Growth Officer (CGO). In his new role,…

Experienced expert in scaling business and growing revenue will expand Reverba’s global market reach.

Seattle, WA – Reverba, a global health engagement company specializing in innovative and compliant patient engagement and medical communication solutions for biopharmaceutical companies, today announced the appointment of Scott Wolf as the company’s Chief Growth Officer (CGO). In his new role, Wolf will lead strategic growth initiatives focusing on expanding Reverba’s market reach, driving business development, and enhancing customer relationships. His leadership will further solidify Reverba’s position as a pioneer in delivering cutting-edge engagement strategies across the biopharma industry.

“We are delighted to welcome Scott to our leadership team. His extensive experience in growth strategies and business development makes him the perfect fit for this role,” said Cheryl Lubbert, CEO of Reverba. “Scott’s passion for customer engagement aligns seamlessly with our mission, and I’m confident his leadership will accelerate our growth and help us achieve our ambitious goals.”

Wolf brings over 20 years of experience in business development, sales, and operational leadership across a range of tech, business-to-business, and consumer industries.

“I am thrilled to join the Reverba team at such an exciting time of innovation and expansion,” said Scott Wolf, Chief Growth Officer of Reverba. “Reverba’s commitment to empowering health consumers through unique engagement solutions resonates deeply with me, and I look forward to collaborating with the team to build on this momentum and achieve new levels of success.”

Wolf joins Reverba from Wolf Media Group, where he was Founder & CEO. Prior to Wolf Media Group, he held the position of Chief Revenue Officer (CRO) for health and wellness website Everyday Health. Over the course of his 10-year career there, Scott grew his division from three to more than 150 employees and grew revenue from $2 million to $200 million. As CRO, Scott was a fundamental part of Everyday Health’s senior executive team, responsible for launching the website and taking the company public, completing an IPO in 2014.

Prior to his time at Everyday Health, Wolf held executive positions at major technology and publishing companies, including CMP Media, Muzak, Vivendi Universal Music Internet Group, and Bidtellect, where he specialized in scaling organizational revenue into the multi-millions.

Wolf holds an MBA degree from the NYU Stern School of Business and graduated with honors from the University of Pennsylvania.

About Reverba

Reverba is a global health engagement company that provides solutions to empower the biopharmaceutical industry to build connections with consumers and better meet the needs of patients through innovative technology and patient-centric approaches from discovery through commercialization.

Recently, Reverba expanded its global footprint through the acquisition of Six Degrees Medical, a leading medical communications agency specializing in medical affairs and scientific engagement. This strategic acquisition enhances Reverba’s ability to deliver comprehensive solutions in clinical trials, medical affairs, patient engagement, and scientific communications, further solidifying its leadership in the industry.

For more than 20 years, Reverba has incorporated compliance throughout its technology platforms and patient engagement solutions, maintaining SOC 2 Type II certification for the highest level of security. Formed from the mergers of Health Advocacy Strategies, Patient Health Perspectives, and Health Perspectives Group, the company rebranded as Reverba in 2021. Health Stories Project, a wholly owned subsidiary of Reverba, is a sharing community about personal health experiences, participation in clinical trials, and other activities.

For more information, visit reverba.com or contact partnerships@em.reverba.com

For media inquiries, please contact:

Kira Gordon
Email: kira@brightpointny.com
Phone: (646) 243-4920

###


The Latest

  • Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes
    Perspective From Patients as Partners: Sustaining Patient Engagement Through Organizational Changes

    At Patients as Partners 2026, CEO Cheryl Lubbert shared how sustaining patient engagement through organizational change requires intentional design, with systems built to hold as teams, priorities, and programs shift.

  • Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?
    Pharma USA 2026: AI Scales Reach in Pharma. But What Actually Changes Patient and HCP Behavior?

    AI is becoming a baseline expectation in pharma. At Pharma USA 2026, discussions reflected less focus on whether AI should be used and more on how it is being applied…

  • Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact
    Approval Is Not the Finish Line: Turning Late-Stage Clinical Evidence Into Real-World Impact

    Late-stage clinical programs establish the evidence required for regulatory evaluation, but they do not guarantee adoption, access, or commercial performance. Translating that evidence into real-world impact requires patient-centered execution and…